{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:54Z","timestamp":1772165694787,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with chronic kidney disease often experience metabolic acidosis. Whether oral sodium bicarbonate can reduce mortality in patients with metabolic acidosis has been debated for years. Hence, this study was conducted to evaluate the utility of sodium bicarbonate in patients who will undergo dialysis therapy. In this study, we investigated the effect of oral sodium bicarbonate therapy on mortality in patients with end-stage kidney disease (ESKD) initiated on dialysis therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an observational study of patients when they started dialysis therapy. There were 17 centres participating in the Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis. Data were available on patients\u2019 sex, age, use of sodium bicarbonate, drug history, medical history, vital data, and laboratory data. We investigated whether patients on oral sodium bicarbonate for more than three months before dialysis initiation had a better prognosis than those without sodium bicarbonate therapy. The primary outcome was defined as all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 1524 patients with chronic kidney disease who initiated dialysis between October 2011 and September 2013. Among them, 1030 were men and 492 women, with a mean age of 67.5\u2009\u00b1\u200913.1\u2009years. Of these, 677 used sodium bicarbonate and 845 did not; 13.6% of the patients in the former group and 21.2% of those in the latter group died by March 2015 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001). Even after adjusting for various factors, the use of sodium bicarbonate independently reduced mortality (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The use of oral sodium bicarbonate at the time of dialysis initiation significantly reduced all-cause mortality in patients undergoing dialysis therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-021-02330-0","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T17:03:01Z","timestamp":1617728581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relationship between mortality and use of sodium bicarbonate at the time of dialysis initiation: a prospective observational study"],"prefix":"10.1186","volume":"22","author":[{"given":"Hikaru","family":"Morooka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijo","family":"Inaguma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"issue":"13","key":"2330_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294\u2013304. https:\/\/doi.org\/10.1001\/jama.2019.14745.","journal-title":"JAMA."},{"issue":"10075","key":"2330_CR2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(16)32064-5.","journal-title":"Lancet."},{"issue":"1","key":"2330_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12916-020-01542-9","volume":"18","author":"BiCARB study group","year":"2020","unstructured":"BiCARB study group. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial. BMC Med. 2020;18(1):91. https:\/\/doi.org\/10.1186\/s12916-020-01542-9.","journal-title":"BMC Med"},{"issue":"2","key":"2330_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/j.ajkd.2009.02.014","volume":"54","author":"SN Shah","year":"2009","unstructured":"Shah SN, Abramowitz M, Hostetter TH, Melamed ML. Serum bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis. 2009;54(2):270\u20137. https:\/\/doi.org\/10.1053\/j.ajkd.2009.02.014.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2330_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","volume":"62","author":"M Dobre","year":"2013","unstructured":"Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2013;62(4):670\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2013.01.017.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2330_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ki.2010.388","volume":"79","author":"KL Raphael","year":"2011","unstructured":"Raphael KL, Wei G, Baird BC, Greene T, Beddhu S. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int. 2011;79(3):356\u201362. https:\/\/doi.org\/10.1038\/ki.2010.388.","journal-title":"Kidney Int"},{"issue":"15","key":"2330_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","volume":"305","author":"N Tangri","year":"2011","unstructured":"Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553\u20139. https:\/\/doi.org\/10.1001\/jama.2011.451.","journal-title":"JAMA."},{"issue":"5","key":"2330_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1053\/j.ajkd.2010.03.023","volume":"56","author":"V Menon","year":"2010","unstructured":"Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, et al. Serum bicarbonate and long-term outcomes in CKD. Am J Kidney Dis. 2010;56(5):907\u201314. https:\/\/doi.org\/10.1053\/j.ajkd.2010.03.023.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2330_CR9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/ndt\/gfn633","volume":"24","author":"CP Kovesdy","year":"2009","unstructured":"Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant. 2009;24(4):1232\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfn633.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2330_CR10","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/ndt\/gfs609","volume":"28","author":"KL Raphael","year":"2013","unstructured":"Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu S. Serum bicarbonate and mortality in adults in NHANES III. Nephrol Dial Transplant. 2013;28(5):1207\u201313. https:\/\/doi.org\/10.1093\/ndt\/gfs609.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2330_CR11","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1681\/ASN.2008111205","volume":"20","author":"I de Brito-Ashurst","year":"2009","unstructured":"de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075\u201384. https:\/\/doi.org\/10.1681\/ASN.2008111205.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2330_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ki.2009.519","volume":"77","author":"S Phisitkul","year":"2010","unstructured":"Phisitkul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab MH, et al. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int. 2010;77(7):617\u201323. https:\/\/doi.org\/10.1038\/ki.2009.519.","journal-title":"Kidney Int"},{"issue":"6","key":"2330_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1159\/000339329","volume":"35","author":"P Susantitaphong","year":"2012","unstructured":"Susantitaphong P, Sewaralthahab K, Balk EM, Jaber BL, Madias NE. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Am J Nephrol. 2012;35(6):540\u20137. https:\/\/doi.org\/10.1159\/000339329.","journal-title":"Am J Nephrol"},{"key":"2330_CR14","doi-asserted-by":"publisher","unstructured":"Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD, et al. Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med. 2016; 129(2): 153\u2013162.e7. doi:https:\/\/doi.org\/10.1016\/j.amjmed.2015.08.025.","DOI":"10.1016\/j.amjmed.2015.08.025"},{"issue":"3","key":"2330_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1681\/ASN.2016070780","volume":"28","author":"MK Abramowitz","year":"2017","unstructured":"Abramowitz MK. Bicarbonate balance and prescription in ESRD. J Am Soc Nephrol. 2017;28(3):726\u201334. https:\/\/doi.org\/10.1681\/ASN.2016070780.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2330_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1159\/000479641","volume":"42","author":"XY Liu","year":"2017","unstructured":"Liu XY, Gao XM, Zhang N, Chen R, Wu F, Tao XC, et al. Oral bicarbonate slows decline of residual renal function in peritoneal dialysis patients. Kidney Blood Press Res. 2017;42(3):565\u201374. https:\/\/doi.org\/10.1159\/000479641.","journal-title":"Kidney Blood Press Res"},{"key":"2330_CR17","doi-asserted-by":"publisher","unstructured":"Hu MK, Witham MD, Soiza RL. Oral bicarbonate therapy in non-haemodialysis dependent chronic kidney disease patients: a systematic review and meta-analysis of randomised controlled trials. J Clin Med. 2019; 8(2): 208. Published. doi:https:\/\/doi.org\/10.3390\/jcm8020208.","DOI":"10.3390\/jcm8020208"},{"issue":"5","key":"2330_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10157-015-1206-z","volume":"20","author":"M Hishida","year":"2016","unstructured":"Hishida M, Tamai H, Morinaga T, Maekawa M, Aoki T, Tomida H, et al. Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy. Clin Exp Nephrol. 2016;20(5):795\u2013807. https:\/\/doi.org\/10.1007\/s10157-015-1206-z.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"2330_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000443314","volume":"132","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Inaguma D, Shinjo H, Murata M, Takeda A. Aichi cohort study of prognosis in patients newly initiated into Dialysis (AICOPP) study group. Presence of atrial fibrillation at the time of dialysis initiation is associated with mortality and cardiovascular events. Nephron. 2016;132(2):86\u201392. https:\/\/doi.org\/10.1159\/000443314.","journal-title":"Nephron"},{"issue":"26","key":"2330_CR20","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441\u20136. https:\/\/doi.org\/10.1056\/NEJM197112232852601.","journal-title":"N Engl J Med"},{"key":"2330_CR21","unstructured":"Shahbaz H, Gupta M. Creatinine clearance. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2020 2 Jan\u2013. PMID: 31334948:2020."},{"key":"2330_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"DE Ho","year":"2011","unstructured":"Ho DE, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Soft. 2011;42:1\u201328.","journal-title":"J Stat Soft"},{"issue":"2","key":"2330_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1681\/ASN.2017040422","volume":"29","author":"KL Raphael","year":"2018","unstructured":"Raphael KL. Metabolic acidosis and subclinical metabolic acidosis in CKD. J Am Soc Nephrol. 2018;29(2):376\u201382. https:\/\/doi.org\/10.1681\/ASN.2017040422.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02330-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-021-02330-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02330-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T17:03:29Z","timestamp":1617728609000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02330-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2330"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02330-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-154538\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Institutional Review Board of Nagoya University Hospital (approval number: 1335), and all patients provided written informed consent. This study was adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}